The abdominal cocoon is a rare disease that is characterized by a total or partial encasement of the small bowel by a thick and fibrotic membrane. Thirty-five cases were reported since it was first described. It occurs primarily in females. Preoperative diagnosis is a matter of challenge and usually made at laparotomy. We report a patient with partial intestinal obstruction and abdominal cocoon which was diagnosed peri-operatively. We review the literature and discuss the etiology of this disease.

Masuda C, Fujii Y, Kamiya T, Miyamoto M, Nakahara K, Hattori S, Ohshita H, Yokoyama T, Yoshida H, Tsutsumi Y: Idiopathic sclerosing peritonitis in a man. Intern Med 1993;32:552–555.
Eltringham WK, Espiner HJ, Windsor CWO, Griffiths DA, Davies JD, Baddeley H, Read AEA, Blunt RJ: Sclerosing peritonitis due to practolol: A report on 9 cases and their surgical management. Br J Surg 1977;64:229–235.
Verger C, Celicout B: Peritoneal permeability and encapsulating peritonitis. Lancet 1985;i:986–987.
Holland P: Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis. Clin Radiol 1990;41:19–23.
Narayaman R, Bhargava BN, Kabra SG, Sangal BC: Idiopathic sclerosing encapsulating peritonitis. Lancet 1989;ii:127–129.
Foo KT, Rauff A, Foong WC, Sinniah R: Unusual small intestinal obstruction in adolescent girls: The abdominal cocoon. Br J Surg 1978;65:427–430.
Rao PLNG, Mitra SK, Pathak IC: Abdominal cocoon – A cause of intestinal obstruction in a 4-year-old girl. Ind Pediatr 1979;16:1047.
Ahmed MN, Kaur S, Zargar HU: Abdominal cocoon: An unusual intestinal obstruction. J Postgrad Med 1984;30:62–63.
Kumar M, Deb M, Parshad R: Abdominal cocoon: Report of a case. Surg Today 2000;30:950–953.
Wig JD, Goenka MK, Nagi B, Vaiphei K: Abdominal cocoon in a male: A rare cause of intestinal obstruction. Trop Gastroenterol 1995;16:31–33.
Sahoo SP, Gangopadhyay AN, Gupta DK, Gopal SC, Sharma SP, Dash RN: Abdominal cocoon in children: A report of four cases. J Pediatr Surg 1996;31:987–988.
Yip FWK, Lee SH: The abdominal cocoon. Aust NZ J Surg 1992;62:638–642.
Seng LK, Mahadaven M, Musa A: Abdominal cocoon: A report of two cases. Br J Surg 1993;80:1149.
Sieck JO, Cowgill R, Larkworthy W: Peritoneal encapsulation and abdominal cocoon: Case report and a review of the literature. Gastroenterology 1983;84:1597–1601.
Sayfan J, Adam YG, Reif R: Peritoneal encapsulation in childhood. Am J Surg 1979;138:725–727.
Deeb LS, Mourad FH, El-Zein YR, Uhman SM: Abdominal cocoon in a man: Preoperative diagnosis and literature review. J Clin Gastroenterol 1998;26:148–150.
Marinho A, Adelusi B: The abdominal cocoon – Case Report. Br J Obstet Gynecol 1980;87(3):249–250.
Le C, Pitcher ME, Jones T: The abdominal cocoon. Aust NZ J Surg 1996;66:777.
Cambria RP, Shamberger RC: Small bowel obstruction caused by the abdominal cocoon syndrome: Possible association with the LeVeen shunt. Surgery 1984;95:501–503.
Brown P, Baddeley H, Read AE, Davis JD, McGarry J: Sclerosing peritonitis, an unusual reaction to a β-adrenergic blocking drug (practolol). Lancet 1974;ii:1477–1481.
Windsor CWO, Kurrein F, Dyer NH: Fibrinous peritonitis: A complication of practolol therapy. Br Med J 1975;ii:68.
Lewin K, McCarthy LJ: Peritoneal encapsulation of the small intestine. Gastroenterology 1970;59:270–272.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.